Logo
  • Economy
  • Investing
  • Latest News
  • Stock
Subscribe to BluePrintForInvestors.com

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Category: Investing

    AI sell-off: 3 sectors it has hit the hardest and why
    Trump moves to soften steel, aluminium tariffs after global trade backlash: report
    Baidu integrates OpenClaw into search as AI agent race heats up in China
    These 3 stocks are quietly soaring as Microsoft, Google slump on AI spending
    Inside the great Indian IT selloff: experts assess AI risks for Infosys, HCL and TCS
    Dow futures plunge ahead of CPI data: 5 things to know before Wall Street opens
    Coinbase stock flips crucial support level as losses jump: can it hit $100?
    Kalshi enters sports insurance, challenging how teams hedge risk
    US inflation eases more than expected to 2.4%; Fed seen staying on hold
    Nvidia stock tumbles over 2%: why investors are booking profits
    Air Canada sees surge in corporate travel as Canada diversifies trade routes
    AppLovin stock crashed after earnings: buy the dip or sell the rip?
    Cisco stock slides 7% as this factor overshadows earnings beat
    Elon Musk pushes X into finance as X Money prepares for global launch
    US jobless claims fall by less than expected to 227,000
    IRS warns many tax refunds could be delayed: here’s why
    US stocks open in the green: Dow surges 300 points, S&P up 0.3%
    Hubspot stock has imploded: can the $1 billion buyback reverse the trend?
    • Previous
    • 1
    • 2
    • 3
    • 4
    • …
    • 119
    • Next
    U.S. News
    • Sarepta Therapeutics shares plunge after disappointing trial data
      Sarepta Therapeutics Inc. shares plunged 37% on …
    • From GE to Kraft Heinz to Corteva: why more US giants are choosing spin-offs
      US conglomerates are increasingly breaking up into …
    • China holds firm on TikTok as US pushes for ownership shift
      On Saturday, China restated its stance on …
    Economy
    • Sarepta Therapeutics shares plunge after disappointing trial data
      Sarepta Therapeutics Inc. shares plunged 37% on …
    • From GE to Kraft Heinz to Corteva: why more US giants are choosing spin-offs
      US conglomerates are increasingly breaking up into …
    • China holds firm on TikTok as US pushes for ownership shift
      On Saturday, China restated its stance on …
    BluePrintForInvestors.com
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    © 2025 BluePrintForInvestors.com. All Rights Reserved.